The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
- PMID: 8968104
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
Abstract
The p16Ink4/CDKN2, D-type cyclins, their partners Cdk4/Cdk6, and pRb constitute a G1 regulatory pathway commonly targeted in tumorigenesis. Genetic, immunochemical, and functional cell cycle analyses showed abnormalities of this pathway in each of 22 human melanoma cell lines examined. Normal melanocytes and all melanoma lines expressed Cdk4, Cdk6, and cyclins D1 and D3. The tumor suppressors p16Ink4/CDKN2 and pRb were lost in 17 and 4 cases, respectively, due to various genetic mechanisms, including transcriptional block of p16 and nonsense mutations of RB1. Ectopic expression of p16 prevented S-phase entry of Rb+/p16- but not Rb-deficient melanoma lines. The SK29-MEL-1 cell line harboring an R24C mutation in Cdk4 expressed wild-type pRb and overabundant p16, the latter preventing endogenous Cdk6 but not Cdk4 from associating with cyclin D1. Microinjection of cyclin D1-neutralizing antibody arrested the SK29-MEL-1 cells in G1, whereas pl6 did not, indicating that the cyclin D1/Cdk4-R24C complex is required for G1 progression, and the resistance of the complex to p16 in vivo. These data strongly support the candidacy of Cdk4 as a novel proto-oncogene, provide further evidence for the p16-cyclin D/Cdk-pRb pathway as a functional unit, and suggest that deregulation of this checkpoint may represent a common step in the multistep progression of sporadic malignant melanomas.
Similar articles
-
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.Nature. 1995 Jun 8;375(6531):503-6. doi: 10.1038/375503a0. Nature. 1995. PMID: 7777060
-
Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.Mol Carcinog. 1998 Jun;22(2):128-43. Mol Carcinog. 1998. PMID: 9655257
-
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.Br J Cancer. 1996 Apr;73(8):909-16. doi: 10.1038/bjc.1996.181. Br J Cancer. 1996. PMID: 8611425 Free PMC article.
-
[Cyclin D, CDK4 and p16 expression in colorectal cancer].Nihon Rinsho. 1996 Apr;54(4):1054-9. Nihon Rinsho. 1996. PMID: 8920673 Review. Japanese.
-
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7. Cancer Radiother. 2001. PMID: 11355576 Review. French.
Cited by
-
Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.Neoplasia. 1999 Aug;1(3):231-40. doi: 10.1038/sj.neo.7900025. Neoplasia. 1999. PMID: 10935478 Free PMC article.
-
Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.Am J Pathol. 1999 Dec;155(6):1855-60. doi: 10.1016/S0002-9440(10)65504-6. Am J Pathol. 1999. PMID: 10595915 Free PMC article.
-
The interplay of CDK4 and CDK6 in melanoma.Oncotarget. 2019 Feb 15;10(14):1346-1359. doi: 10.18632/oncotarget.26515. eCollection 2019 Feb 15. Oncotarget. 2019. PMID: 30858922 Free PMC article.
-
Artichoke as a melanoma growth inhibitor.Med Oncol. 2023 Aug 7;40(9):262. doi: 10.1007/s12032-023-02077-8. Med Oncol. 2023. PMID: 37544953
-
MAP Kinase Pathways: Molecular Roads to Primary Acral Lentiginous Melanoma.Am J Dermatopathol. 2015 Dec;37(12):892-7. doi: 10.1097/DAD.0000000000000317. Am J Dermatopathol. 2015. PMID: 26588333 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous